TC
NVO

TownSquare Capital’s Novo Nordisk NVO Stock Holding History

TownSquare Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
8,082
+1,698
+27% +$80.5K 0.07% 195
2025
Q4 		$325K Sell
6,384
-14,616
-70% -$747K 0.07% 181
2025
Q3 		$1.17M Sell
21,000
-13,141
-38% -$769K 0.18% 119
2025
Q2 		$2.36M Sell
34,141
-264,082
-89% -$18M 0.23% 97
2025
Q1 		$20.7M Sell
298,223
-61,766
-17% -$5.1M 0.22% 87
2024
Q4 		$31M Sell
359,989
-18,784
-5% -$2.03M 0.35% 56
2024
Q3 		$45.1M Sell
378,773
-11,207
-3% -$1.49M 0.54% 33
2024
Q2 		$55.7M Buy
389,980
+46,324
+13% +$6.14M 0.76% 23
2024
Q1 		$44.1M Buy
343,656
+1,456
+0.4% +$173K 0.65% 34
2023
Q4 		$35.4M Sell
342,200
-17,552
-5% -$1.74M 0.61% 35
2023
Q3 		$32.7M Buy
359,752
+110,802
+45% +$9.76M 0.6% 36
2023
Q2 		$20.1M Buy
248,950
+38,610
+18% +$3.15M 0.37% 66
2023
Q1 		$16.7M Sell
210,340
-32,340
-13% -$2.29M 0.37% 64
2022
Q4 		$16.4M Buy
242,680
+5,100
+2% +$299K 0.41% 60
2022
Q3 		$11.8M Buy
237,580
+6,018
+3% +$322K 0.34% 64
2022
Q2 		$12.9M Buy
231,562
+4,650
+2% +$258K 0.37% 60
2022
Q1 		$12.6M Buy
226,912
+19,106
+9% +$981K 0.32% 65
2021
Q4 		$11.6M Buy
207,806
+25,046
+14% +$1.36M 0.29% 72
2021
Q3 		$8.77M Buy
182,760
+2,446
+1% +$118K 0.25% 78
2021
Q2 		$7.67M Buy
180,314
+28,198
+19% +$1.09M 0.25% 79
2021
Q1 		$5.13M Buy
152,116
+990
+0.7% +$35.3K 0.2% 92
2020
Q4 		$5.28M Buy
151,126
+15,726
+12% +$544K 0.23% 85
2020
Q3 		$4.68M Buy
135,400
+20,300
+18% +$677K 0.27% 73
2020
Q2 		$3.75M Buy
115,100
+1,392
+1% +$44.4K 0.25% 79
2020
Q1 		$3.61M Buy
113,708
+28,452
+33% +$847K 0.29% 66
2019
Q4 		$2.47M Buy
85,256
+14,672
+21% +$406K 0.2% 94
2019
Q3 		$1.99M Buy
70,584
+15,500
+28% +$392K 0.16% 108
2019
Q2 		$1.34M Sell
55,084
-113,684
-67% -$2.81M 0.13% 132
2019
Q1 		$4.41M Buy
168,768
+74,282
+79% +$1.83M 0.34% 70
2018
Q4 		$2.31M Buy
+94,486
New +$2.1M 0.3% 69

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

TownSquare Capital's NVO Position: Q1 2026 in Review

TownSquare Capital increased its Novo Nordisk (NVO) stake by 27% in Q1 2026, buying an estimated $80.5K and bringing the position to 8,082 shares worth $297K. The position accounts for 0.07% of the portfolio, ranked #195.

TownSquare Capital first reported a position in NVO in Q4 2018 and has held it in 30 quarters since. The position peaked at $55.7M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • TownSquare Capital held 8,082 shares of Novo Nordisk worth $297K as of Q1 2026.
  • TownSquare Capital bought 1,698 Novo Nordisk shares in Q1 2026, an estimated $80.5K.
  • Novo Nordisk made up 0.07% of TownSquare Capital's portfolio in Q1 2026, its #195 holding.
  • TownSquare Capital first reported a position in Novo Nordisk in Q4 2018 and has held it in 30 quarters since.
  • TownSquare Capital's Novo Nordisk position peaked at $55.7M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on TownSquare Capital's 13F filing for Q1 2026, filed 13 May 2026.